Jeffrey Goldberg
Keine laufenden Positionen mehr
Karriereverlauf von Jeffrey Goldberg
Ehemalige bekannte Positionen von Jeffrey Goldberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPYRE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.11.2022 | 16.05.2023 |
Vorstandsvorsitzender | 29.11.2022 | 16.05.2023 | |
Präsident | 29.11.2022 | 16.05.2023 | |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 18.12.2019 | 16.11.2021 |
Vorstandsvorsitzender | 18.12.2019 | 16.11.2021 | |
Präsident | - | 16.11.2021 | |
AKCEA THERAPEUTICS, INC. | Geschäftsführer | 01.01.2015 | 23.09.2019 |
PROTEOSTASIS THERAPEUTICS, INC. | Geschäftsführer | 01.01.2012 | 01.01.2014 |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Jeffrey Goldberg
Cornell University | Undergraduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SPYRE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jeffrey Goldberg
- Erfahrung